Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 17, 2026Expert Opinion on Pharmacotherapy

New and emerging somatostatin therapies for neuroendocrine tumors: “what is in the pipeline”

View Full Paper
Ask AI
Bookmark
Share

Authors

LLLingaku LeeTITetsuhide ItoRJRobert T. Jensen

Discussion

Loading...

Member takes

Overview

Expert review reveals advancing somatostatin receptor-targeted therapies in neuroendocrine neoplasms, highlighting novel radioligands and oral agents to overcome resistance.

Key Points

  • To summarize emerging somatostatin receptor-targeted therapies, novel pharmacological agents, and updated clinical protocols in the management of neuroendocrine neoplasms.
  • Narrative review evaluating preclinical and clinical developments for non-radiolabeled and radiolabeled somatostatin analogs (SSTAs).
  • Analysis of novel formulations including oral agents, nonpeptide receptor antagonists, alpha- and beta-emitting radioligands, and combination regimens.
  • Novel cold and radiolabeled SSTAs are entering pipelines, including orally bioavailable compounds, receptor antagonists, and longer-acting agents designed to reverse treatment resistance.
  • Peptide receptor radionuclide therapy (PRRT) is expanding via alpha-emitting radionuclides, radiosensitizing combinations, and extended protocols for pediatric and retreatment settings.
  • Combination strategies linking SSTAs with mTOR inhibitors, tyrosine kinase inhibitors, chemotherapy, or immunotherapy show promise for enhanced anti-proliferative and cytotoxic effects.

Cite This Study

Lee et al. (2026) studied this question.

synapsesocial.com/papers/6aabb6d85f706d05830e584ahttps://doi.org/10.1080/14656566.2026.2735443
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeted radionuclide therapy and diagnostic imaging of SSTR positive neuroendocrine tumors: a clinical update in the new decade2025 · 8 citations
  2. 2SSTR-Based Therapies for Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms2026
  3. 3From Bench to Bedside: A Critical Appraisal of Somatostatin Receptor Antagonists in the Theranostic Management of Neuroendocrine Neoplasms2026
  4. 4Emerging Diagnostics and Therapies in Neuroendocrine Neoplasms: A Critical Review2025
  5. 5Theranostics in Neuroendocrine Neoplasms: The Multifaceted Aspects Integrating Imaging, Therapy, and Dosimetry.2026